US3675766A - Multiple puncture injector device - Google Patents

Multiple puncture injector device Download PDF

Info

Publication number
US3675766A
US3675766A US8625A US3675766DA US3675766A US 3675766 A US3675766 A US 3675766A US 8625 A US8625 A US 8625A US 3675766D A US3675766D A US 3675766DA US 3675766 A US3675766 A US 3675766A
Authority
US
United States
Prior art keywords
base plate
injector
handle
container
tines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US8625A
Inventor
Sol Roy Rosenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3675766A publication Critical patent/US3675766A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/20Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205Vaccinating by means of needles or other puncturing devices

Definitions

  • ABSTRACT [52] US. Cl ..206/63.4, 128/253 A multiple puncture injector device for use in transcutaneous [51] Int. Cl. ..A6lb 19/02, B65d 81/20 injection, the injector having a handle hingedly connected to [58] Field of Search ..206/63.4, 63.2, 56A, 56 AB; the top surface of a base plate and movable between a use 128/253, 333, 314, 329; 15/253 position in which the handle extends outwardly of the base plate and a storage position in which the handle is substan- I 56] References Cited tially parallel to the base plate to facilitate storage thereof; the base plates may be straight or arcuate; the handles may be UNITED STATES PATENTS locked in the use and storage positions.
  • the injectors can be 3,289,670 12/1966 Krug et al packaged in vacuum-packed hermetically sealed containers, 3,131,410 1964 Anderson et a] which containers are connected one to another in end-to-end 3,444939 1969 "@1161 el relationship to facilitate the detachment of a selected one of 3,22 1 1 Rosenthal the packages 2,817,336 12/1957 Kravitz et al.... 3,070,102 12/1962 MacDonald ..206/56 A 20 China, 18 Drawing Figures PKTENTEDJUL H 1972 3, 675.76 6
  • This invention relates to a multiple puncture injector device for use in transcutaneous injection and more particularly to an injector with either a straight base or an arcuate base with a handle hingedly secured thereto to facilitate easy storage thereof.
  • An important object of the present invention is to provide a transcutaneous injector comprising a base plate having a top surface and a bottom surface, a plurality of tines carried by the bottom surface of the base plate extending outwardly therefrom and substantially normal thereto, and a handle hingedly connected to the top surface of the base plate, the handle being movable between a use position in which the handle is substantially normal to the base plate and extends outwardly therefrom and a storage position in which the handle is substantially parallel to the base plate to facilitate the storage ofthe injector.
  • Another object of the present invention is to provide a prepared package for an injector of the type set forth including a vacuum-packed hermetically sealed container disposed completely about the injector when the handle of the injector is in the storage position.
  • a further object of the present invention is to provide a series of prepared packages connected one to another in end-toend relationship, the connectionsbeing adapted easily to be broken to detach a selected one of the series of prepared packages without detaching the others of the series of prepared packages, each of the packages being of the type set forth with the containers thereof having connecting flanges extending outwardly therefrom.
  • a further object of the present invention is to provide a transcutaneous injector comprising an arcuate base plate having a concave top surface and a convex bottom surface, a plurality of tines carried by the convex bottom surface of the base plate and extending outwardly therefrom, and a handle connected to the concave top surface of the base plate and extending outwardly therefrom, the injector being adapted to be rolled against the skin to puncture the skin at a plurality of points and introduce a biological substance carried by the tines into the body.
  • a still further object of the present invention is to provide a prepared package for an injector with an arcuate base plate of the type set forth, the package including a vacuum-packed hermetically sealed container disposed completely about the injector when the handle of the injector is in the storage positron.
  • FIG. 1 is a view in vertical section of a transcutaneous injector incorporating therein features of the present invention
  • FIG. 2 is a perspective view of a series of prepared packages for the injector of FIG. 1, one of the prepared packages having the cover off to show the inside arrangement thereof;
  • FIG. 3 is a side elevational view partly in vertical section of a series of prepared packages for the injector of FIG. 1;
  • FIG. 4 is a plan view of a portion of the series of prepared packages of FIG. 3;
  • FIG. 5 is a perspective view of an embodiment of a handle for the injector of FIG. 1;
  • FIG. 6 is a perspective view of an embodiment of a handle for the injector of FIG. 1;
  • FIG. 7 is a side elevational view of an injector having a fixed handle and an arcuate base
  • FIG. 8 is a bottom view of the injector of FIG. 7;
  • FIG. 9 is a side elevational view of an injector having a hinged handle and an arcuate base
  • FIG. 10 is a side elevational view partly in vertical section of a series of prepared packages for the injector of FIGS. 1;
  • FIG. 11 is a view in vertical section of the injector of FIG. 9 disposed within a vacuum-packed hermetically sealed container;
  • FIG. 12 is a side elevational view of a series of the packages of FIG. 11;
  • FIG. 13 is a plan view of an embodiment of the transcutaneous injector of FIG. 1;
  • FIG. 14 is a side elevational view of the injector of FIG. 13;
  • FIG. 15 is a view in vertical section of an injector mounted in a vacuum-packed hermetically sealed container
  • FIG. 16 is a plan view of the container of FIG. 15 without the injector disposed therewithin;
  • FIG. 17 is a view in vertical section of a transcutaneous injector having means for locking the handle thereof in the use and storage positions thereof;
  • FIG. 18 is a side elevational view partly broken away of the injector of FIG. 17.
  • an injector having a substantially flat base plate 101, the base plate 101 including a top surface 102 anda bottom surface 103 spaced apart and parallel thereto. Extending upwardly, from opposed side edges of the bottom surface 102 are two spaced-apart and generally parallel abutment surfaces 104, each ofthe abutment surfaces 104 leading to a shoulder 105. generally parallel to the top surface 102.
  • Two parallel spaced-apart grooves 106 are cut into the bottom surface 103 and extend for a predetermined distance from the bottom surface 103 toward the top surface 102, the grooves 106 being spaced apart a preselected distance to receive therein a metal plate 107 having upturned flanges 108, the flanges 108 being spaced apart a predetermined distance and being of a predetennined length securely to fit within the grooves 106.
  • the metal plate 107 may be mounted in the base plate 101 in a variety of ways, the abovedescribed method being selected merely for purposes of illustration. Outwardly depending from and substantially normal to the metal plate 107 are a plurality of tines 1 10, the tines 1 10 carrying on the ends thereof distal from the metal plate 107 a biological substance 111.
  • the injector 100 is provided with a handle 115, the handle being connected to the topsurface 102 of the base plate 101 and positioned generally parallel to the side edges of the base plate 101, the handle 115 further including two spacedapart and parallel side walls 1 16 interconnected by a top wall 117 and two parallel spaced-apart end walls 118.
  • the handle 115 is hingedly connected to the top surface 102 of the base plate 101 by a hinge 120, the hinge 120 being integral with the handle 115 and the base plate 101 and being of reduced cross section as compared to the handle 115.
  • the handle 1 15 is movable between a use position, as shown in FIG. 1, in which the handle 115 is substantially normal to the base plate 101 and extends outwardly therefrom and a storage position in which the handle 115 is substantially parallel to the base plate 101 to facilitate the storage of the injector 100, all as hereinafter explained.
  • the injector 100 in position to be packaged, the injector 100 being provided with a U-shaped cover 125, the U- shaped cover including two parallel spaced-apart side walls 126 interconnected by a bottom wall 127, the top edge of each of the side walls 126 forming an abutment surface 128.
  • the side walls 126 of the U-shaped cover 125 are spaced apart a predetermined distance so as to receive thereon the shoulders 105 of the injector 100 and firmly to engage the abutment surfaces 104 of the injector 100 with the adjacent side wall 126 of the U-shaped cover 125.
  • the vertical lengths of the side walls 126 are selected so as to position the bottom wall 127 of the U-shaped cover 125 away from the tines 110 and the biological substances 1 11 carried thereon when the injector 100 is positioned in use on the U-shaped cover 125, thereby to maintain the tines 110 out of contact with the container material as hereinafter explained.
  • a container 130 for the combination of the injector 100 and the U-shaped cover 125 including a top layer 131 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid.
  • the top layer 131 has extending outwardly completely around the periphery thereof a top flange 132.
  • the container 130 further includes a bottom layer 133 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid.
  • the bottom layer 133 is disposed about the U-shaped cover 125 to substantially encircle the same and includes a bottom flange 134 extending completely around the periphery of the U-shaped cover 125, which flange 134 is substantially coextensive with the top flange 132.
  • the top flange 132 and the bottom flange 134 are of the type of synthetic plastic resin which seals when heated, thereby to form a container 130 suitable for the storage of the injector 100 when the tines 110 thereof carry a non-living biological substance thereon, the container 130 being sealed after the injector 100 has been sterilized with ethylene oxide gas or by other means well known in the art.
  • the injector 100 When the tines 110 of the injector 100 carry thereon a living biological substance, the injector 100 must be stored under vacuum and the container 130 must be hermetically sealed to prevent the biological substance from being contacted by air or moisture.
  • the container 130 may be made from glass or a metal foil, as previously disclosed in my co-pending patent application entitled VACUUM-PACKED I-IERMETICALLY SEALED MULTI- PLE PUNCTURE DEVICE, filed on June 16, 1969, Ser. No. 833,299.
  • top flange 132 of the bottom flange 134 or both are scored as at 135 to provide connections between a series of prepared packages 140 connected one to another in end-to-end relationship, the connections therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 140 without detaching the others of the series of prepared packages.
  • an injector 200 having a substantially flat base plate 201, the base plate 201 including a top surface 202 and a bottom surface 203 spaced apart and parallel thereto. Extending upwardly from opposed side edges of the bottom surface 202 are two spacedapart and generally parallel abutment surfaces 204 leading to a shoulder 205 generally parallel to the top surface 202.
  • Two parallel spaced-apart grooves are cut into the bottom surface 203 and extend for a predetermined distance from the bottom surface 203 toward the top surface 202, the grooves being spaced apart a preselected distance to receive therein a metal plate 207 having upturned flanges (not shown), the flanges being spaced apart a predetermined distance and of a predetermined length securely to fit within the grooves.
  • Outwardly depending from and substantially normal to the metal plate 207 are a plurality of tines 210, the tines 210 carrying on the ends thereof distal from the metal plate 207 a biological substance 21 l.
  • the injector 200 is provided with a handle 215, the handle 215 being connected to the top surface 202 of the base plate 201 and positioned generally parallel to the side edges of the base plate 201, the handle 215 further including two spacedapart and parallel side walls 216 interconnected by a top wall 217 and two spaced-apart end walls 218.
  • the handle 215 is hingedly connected to the top surface 202 of the base plate 201 by a hinge 220 being integral with the handle 215 and being of reduced cross section as compared to the handle 215.
  • the handle 215 is movable between a use position, as shown in the left-hand portion of FIG.
  • the injector 200 in position to be packaged in a container 230, the container 230 including a top layer 231 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid.
  • the top layer 231 has extending outwardly completely around the periphery thereof, a top flange 232, see particularly FIG. 4.
  • the container 230 further includes a bottom layer 233 of synthetic plastic resin which is rigid and retains its shape and rigidity when subjected to moderately elevated temperatures, the bottom layer 233 including two parallel spaced-apart side walls 236 interconnected by a bottom wall 237, the top edges of the side walls 236 being formed into shoulders 238.
  • a bottom flange 234 extends outwardly completely around the periphery of the bottom layer 233, the bottom flanges 234 of adjacent containers 230 being connected and scored as at 235 to provide connections between a series of prepared packages 240 connected one to the other in end-to-end relationship, the connection therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 230 without detaching the others of the series of prepared packages.
  • the bottom layer 233 of the container 230 performs the same function as the U-shaped cover 125 previously described in that the side walls 236 and shoulders 238 thereon are spaced apart a predetermined distance so as to receive thereon the shoulders 205 of the injector 200 and firmly to engage the abutment surface 204 of the injector 200 with the adjacent side wall 236 of the bottom layer 233.
  • the vertical lengths of the side walls 236 are selected so as to position the bottom wall 237 of the bottom layer 233 away from the tines 210 and the biological substance 21l carried thereby when the injector 200 is positioned within the container 230, thereby to maintain the tines 210 out of contact with the container 230.
  • an internal ridge (not shown) positioned on the bottom wall 237 of the bottom layer 233 of the container 230 may be used to support the injector 200 when the injector 200 is disposed within the container 230, thereby to maintain the tines 210 out of contact with the container 230.
  • the container 230 herein may also be made impervious to air and moisture, i.e., hermetically sealed, for the storage of an injector 200 carrying on the tines 210 thereof a living biological substance, all as hereinbefore explained.
  • an injector 300 having a substantially flat base plate 301, the base plate 301 including a top surface 302 and a bottom surface 303 spaced apart and parallel thereto. Extending upwardly from opposed side edges of the bottom surface 302 are two spacedapart and generally parallel abutment surfaces 304 leading to a shoulder 305 generally parallel to the top surface 302.
  • Two parallel spaced-apart grooves are cut into the bottom surface 303 and extend for a predetermined distance from the bottom surface 303 toward the top surface 302, the grooves being spaced apart a preselected distance to receive therein a metal plate 307 having upturned flanges (not shown), the flanges being spaced apart a predetermined distance and of a predetermined length securely to fit within the grooves.
  • Outwardly depending from and substantially normal to the metal plate 307 are a plurality of tines 310, the tines 310 carrying on the ends thereof distal from the metal plate 307 a biological substance 31 1.
  • the injector 300 is provided with a handle 315, the handle 315 being connected to the top surface 302 of the base plate 301 and positioned generally parallel to the side edges of the base plate 301, the handle 315 further including two spacedapart and parallel side walls 316 interconnected by a top wall 317 and two spaced-apart end walls 318.
  • the handle 315 is hingedly connected to the top surface 302 of the base plate 301 by a hinge 320 being integral with the handle 315 and Referring now to the middle portion of FIG.
  • the injector 300 in position to be packaged in a container 330, the container 330 including a top layer 331 of a rigid synthetic plastic resin having extending outwardly therefrom and completely around the periphery thereof a top flange 332.
  • the container 330 further includes a bottom layer 333 of a rigid synthetic plastic resin, the bottom layer 333 including two parallel side walls 336 interconnected by a bottom wall 337. Spaced a preselected distance from the bottom wall 337 along each of the side walls 336 is a shoulder 338, the shoulders 338 being cut into the respective side walls 336 to provide a portion 339 of the side walls 336 extending above the shoulders 338 having a reduced thickness.
  • the portions 339 of the side walls 336 extend upwardly and are formed into a bottom flange 334 extending completely around the periphery of the bottom layer 333, the bottom flanges 334 being substantially coextensive with the upper flanges 332 and being secured and scored as at 335 to provide connections between a series of prepared packages 340 connected one to the other in end-to-end relationship, the connections therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 340 without detaching the others of the series of prepared packages.
  • the side walls 336 and particularly the portions 339 having a reduced thickness are spaced apart a predetermined distance so as to receive therein and on the shoulders 338 formed thereby the shoulders 305 of the injector 300 and firmly to engage the abutment surfaces 304 of the injector 300 with the adjacent side walls 336 of the bottom layer 333 of the container 330.
  • the lengths of the side walls 336 are selected so as to position the injector 300 completely within the vertical extent thereof when the handle 315 of the injector 300 is in the storage position thereof and to position the bottom wall 337 of the container 330 away from the tines 310 and the biological substances 311 carried thereon when the injector 300 is positioned for storage within the container 330, thereby to maintain the tines 310 out of contact with the container 330.
  • the container 330 herein may also be made impervious to air and moisture, i.e., hermetically sealed, for the storage of an injector 300 carrying on the tines 310 thereof a living biological substance, all as hereinbefore explained.
  • an injector 400 having an arcuate base plate 401, the arcuate base plate 401 including a concave top surface 402and a convex bottom surface 403, the convex bottom surface 403- being spaced apart and generally parallel to the top surface 402. Extending diagonally upwardly from opposed side edges of the convex bottom surface 403 are two spaced-apart abutment surfaces 404, each of the abutment surfaces 404 leading to a shoulder 405, the shoulders 405 extending diagonally outwardly and away from the adjacent abutment surface 404 to form an inverted V therebetween.
  • Two spaced-apart grooves 406 are cut into the convex bottom surface 403 extending toward the concave top surface 402, the grooves 406 being spaced apart a preselected distance to receive therein a metal plate 407 having upturned flanges 408, the flanges 408 being spaced apart a predetermined distance and being of a predetermined length securely to fit within the grooves 406.
  • Outwardly depending from the metal plate 407 are a plurality of tines 410, the tines 410 carrying on the ends thereof distal from the metal plate 407 a biological substance 411.
  • the injector 400 is provided with a handle 415, the handle 415 being fixedly connected to the concave top surface 402 of the arcuate base plate 401 as at 420.
  • the handle 415 forms a plane parallel to the direction in which the injector 400 is rolled to introduce the biological substance 411 on the distal ends of the tines 410 into a body, all as hereinafter explained.
  • an injector 500 having a base plate 501 with a top surface 502.
  • a handle 515 Disposed upon the top surface 502 of the injector 500 is a handle 515, the handle 515 being an alternate embodiment for the handle 415 for the injector 400 or being an alternate embodiment for the handle 115 of the injector 100.
  • the handle 515 is hingedly connected as at 520 to the base plate 501, as hereinbefore described with reference to injectors 100, 200 and 300.
  • the handle 515 includes two spaced-apart generally parallel side walls 516 interconnected by a pair of upstanding end walls 517 and a top wall 518.
  • Each of the side walls 516 has a vertical portion 521 extending downwardly from the top wall 518, a lower arcuate portion 522 extending upwardly from the top surface 502 of the base plate 501 and an arcuate gripping section 523 intermediate the vertical portion 521 and the arcuate portion 522 and interconnecting the same to form a handle 515 easily gripped by the fingers to manipulate the injector 500.
  • an injector 600 having a base plate 601 with a top surface 602. Disposed upon the top surface 602 of the injector 600 is a handle 615, the handle 615 being an alternate embodiment for the handle of the injector 100.
  • the handle 615 is hingedly connected as at 620 to the base plate 601, the hinged connections 620 being spaced apart to allow the handle 615 to assume a storage position wherein the handle 615 is substantially parallel to the base plate 601.
  • the handle 615 is S-shaped and includes two spaced-apart generally parallel side walls 616 interconnected by two spaced-apart end walls 617 and a top wall 618.
  • the side walls 616 are complementary in shape and are formed of a right-hand curve as at 621 which leads to a left-hand curve as at 622, all as viewed in FIG. 6, to form a handle 615 easily gripped by the fingers to manipulate the injector 600.
  • an injector 700 having an arcuate base plate 701, the arcuate base plate 701 including a concave top surface 702 and a convex bottom surface 703 being spaced apart and generally parallel to the top surface 702. Extending diagonally upwardly from opposed side edges of the convex bottom surface 703 are two spaced-apart abutment surfaces 704, each of the abutment surfaces 704 leading to a shoulder 705, the shoulders 705 extending diagonally outwardly and away from the adjacent abutment surface 704 to form an inverted *V therebetween.
  • Two spaced-apart grooves are cut into the convex bottom surface 703 extending toward the concave top surface 702, the grooves being spaced apart a preselected distance to receive therein a metal plate 707 having upturned flanges (not shown), the flanges being spaced apart a predetermined distance and being of a predetermined length securely to fit within the grooves.
  • Outwardly depending from the metal plate 707 are a plurality of tines 710, the tines 710 carrying on the ends thereof distal from the metal plate 707 a biological substance 711.
  • the injector 700 is provided with a handle 715, the handle 715 being connected to the concave top surface 702 of the arcuate base plate 701 and including two spaced-apart arcuate and parallel side walls 716 interconnected by a top wall 717 and end walls 718.
  • the handle 715 is hingedly connected to the concave top surface 702 of the arcuate base plate 701 adjacent one of the side edges thereof by a hinge 720, the hinge 720 being integral with the handle 715 and the arcuate base plate 701 and being of reduced cross section as compared to the handle 715.
  • the handle 715 is movable between a use position (the solid line position in FIG.
  • the degree of curve of the side walls 716 of the handle 715 is selected so that the handle 715 securely fits adjacent to the concave top surface 702 of the arcuate base plate 701 when the handle 715 is in the storage position thereof.
  • the injector 700 in a container 730, the container 730 including a top layer 731 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid.
  • the top layer 731 has extending outwardly completely around the periphery thereof a top flange 732.
  • the container 730 further includes a bottom layer 733 of synthetic plastic resin which is rigid and retains its shape and rigid character when subjected to moderately elevated temperatures, the bottom layer 733 includes two parallel spaced-apart side walls 736 interconnected by a bottom wall 737, the top edge of the side walls 736 being formed into shoulders 738.
  • a bottom flange 734 extends outwardly completely around the periphery of the bottom layer 733, the bottom flanges 734 of adjacent containers 730 being connected and scored as at 735 to provide connections between a series of prepared packages 740 connected one to the other in end-to-end relationship, the connections therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 740 without detaching the others of the series of prepared packages.
  • the bottom layer 733 of the hermetically sealed container 730 performs the same function as the U-shaped cover 125 previously described in that the side walls 736 and shoulders 738 thereon are spaced apart a predetermined distance so as to receive thereon the shoulders 705 of the injector 700 and firmly to engage the abutment surfaces 704 of the injector 700 with the adjacent side wall 736 of the bottom layer 733.
  • the vertical lengths of the side walls 736 are selected so as to position the bottom wall 737 of the bottom layer 733 away from the tines 710 and the biological substance 711 carried thereby when the injector 700 is positioned in use within the container 730, thereby to maintain the tines 710 out of contact with the container 730.
  • the container 730 herein may also be made impervious to air and moisture, i.e., hermetically sealed, for the storage of an injector 700 carrying on the tines 710 thereof a living biological substance, all as hereinbefore explained.
  • an injector 800 having a substantially flat base plate 801, the base plate 801 including a top surface 802 and a bottom surface 803 spaced apart and parallel thereto. Extending upwardly from opposed side edges of the bottom surface 802 are two spacedapart and generally parallel abutment surfaces 804.
  • Two spaced-apart grooves 806 are cut into the bottom surface 803 and extend diagonally upwardly toward the top surface 802 for a predetermined distance from the bottom surface 803, the grooves 806 being spaced-apart a preselected distance to receive therein a metal plate 807 having diagonally upturned flanges 808, the flanges 808 being spaced-apart a predetermined distance and of a predetermined angle and being of a predetermined length securely to fit within the grooves 806.
  • Outwardly depending from and substantially normal to the base plate 807 are a plurality of tines 810, the tines 810 carrying on the ends thereof distal from the metal plate 807 a biological substance 81 1.
  • the injector 800 is provided with a handle 815, the handle 815 being connected to the top surface 802 of the base plate 801 and positioned generally diagonally to the side edges of the base plate 801, Le, from comer to corner thereof, the handle 815 further including two spaced-apart and parallel side walls 816 interconnected by a top wall 817 and two spaced-apart end walls 818.
  • the handle 815 is hingedly connected to the top surface 802 of the base plate 801 by a hinge 820, the hinge 820 being integral with the handle 815 and the base plate 801 and being of reduced cross section as compared to the handle 815.
  • the handle 815 is movable between a use position in which the handle 815 is substantially normal to the base plate 801 and extends outwardly therefrom and a storage position in which the handle 815 is substantially paral lel to the base plate 801 to facilitate the storage of the injector 100.
  • the diagonal positioning of the handle 815 is advantageous in that it provides for a better gripping surface when using the injector 800 for inoculation purposes.
  • FIGS. 15 and 16 there is disclosed an injector 900 similar in construction to the injector 100 with the metal plate 907 being mounted to the base plate 901 in a fashion similar to that disclosed in injector 800. It is seen, therefore, that the metal plate 900 carrying the tines 910 depending therefrom may be mounted to the base plate 901 by various methods, the particular method chosen herein being a matter of choice.
  • the injector 900 may optionally include two buttons or knobs 905 depending from the bottom surface 903 of the base plate 901 and spaced apart 180, the number of knobs 905 in excess of two and the angular placement thereof being a matter of choice.
  • the injector 900 is provided with a handle 915, which handle 915 is of the same type as hereinbefore disclosed and may be positioned as shown, generally parallel to the side edges of the base plate 901 or positioned diagonally with respect thereto.
  • a container 930 which container may be made of glass if the biological substance 911 carried by the tines 910 is a living substance to hermetically seal the same, the container 930 including a side wall 931 and a bottom wall 932, a top (not shown) is provided for the container 930, which top may be hermetically sealed to the side wall 931.
  • a spacer ring 935 Disposed within the container 930 is a spacer ring 935, the spacer ring 935 being generally annular in shape and having spaced at intervals around the periphery thereof beveled side spacers 936.
  • the beveled side spacers 936 serve to position the spacer ring 935 within the container 930 and to position the injector 900 in registry over the spacer 935 when the injector 900 is introduced into the container 930, as hereinafter explained.
  • the spacer ring 930 is further provided with knob or button receptacles 937 spaced in angular relationship corresponding to the angular relationship between the knobs or buttons 905 depending from the base plate 901 of the injector 900 and the number of buttons 905 which may be used.
  • the beveled side spacers 936 of the spacer ring 935 guide the injector 900 to a registry position above the spacer ring 935.
  • the injector 900 is rotated until the knobs or buttons 905 are positioned above and fit within the receptacles 937, thereby to position the injector 900 in the storage condition thereof within the receptacle 937, it being noted that the vertical length of the spacer ring 935 is of sufficient distance to maintain the tines 910 out of contact with the container 930. Subsequent hermetic sealing of the container 930 under vacuum will provide for a substantial shelf life of the living biological substance 911 carried by the tines 910.
  • FIGS. 17 and 18 there is disclosed therein an injector 1000 similar in construction to the injector 900 except that there is provided spaced apart and upwardly extending and generally parallel side walls 1004, each of the side walls 1004 carrying on the inside surface thereof two spacedapart button receptacles 1005 each positioned near a respective end of the side wall 1004 adjacent to the top wall 1002 of the base plate 1001.
  • the handle 1015 is provided on each end wall 1018 thereof with a button 1019 adapted to fit within one of the receptacles 1005.
  • buttons 1019 are positioned within their respective button receptacles 1005, thereby to lock the handle 1015 in the storage position thereof.
  • the handle 1015 is in the use position thereof, the phantom-line position in FIG. 17 and the full-line position in FIG. 18, the handle 1015 is maintained in position by the positioning of the handle of the user.
  • the side walls 1004 of the injector 1000 are made of resilient material, thereby to permit dislodgement of the buttons 1019 from the respective receptacles 1005 therefor in order to move the handle 1015 from the use position thereof to the storage position thereof, the side walls 1004 having a vertical extent about the distance above the base plate 1002 as the handle 1015 is in the storage position thereof.
  • the upwardly extending side walls 1004 are but one means for locking the handle 1015 in the desired position thereof, it being understood that other friction members may be used to accomplish the same purpose and it is intended that the above-illustrated means is but one illustration of locking means for the hinged handle of the present invention.
  • the metal plates hereinbefore described are relatively thin, about 0.025 millimeters thick and have depending therefrom relatively short tines about 2 millimeters in length, the tines being spaced apart from about 2 to millimeters, depending on the type of innoculation to be performed, the tines being spaced from the edge of the base plate about 1.5 to about 3.5 millimeters.
  • the biological substance is applied to the distal l millimeter of the tines and thereafter dried or freeze-dried. The biological substance is introduced into the body through the skin when the injector and the tines are pressed by a person holding the injector against the skin.
  • the inoculation with a multiple puncture disc having a substantially flat base plate of the type illustrated in FIGS. 1 to 4 and 10 herein, is well known in the art and these devices, in general, are the subject of US. Pat. Nos. 2,619,962; 3,072,122; 3,221,739 and 3,221,740, all issued to
  • the biological substance placed on the tines may be chosen from a living virus such as small pox, measles, yellow fever, rabies, influenza, mumps or german measles; a living bacteria such as bacillus Calmette and Guerin (BCG), H37Ra (human attenuated tubercle bacilli); a non-living substance for skin testing for tuberculins, histoplamims, coccidioidins, sensitins in general or allergens; or a non-living substance for vaccinating for typhoid, paratyphoid, cholera or pertussis.
  • the biological substance is a living or visible bacteria or virus
  • prolonged contact with air or moisture is detrimental and the shelf life of any of the injectors described herein carrying a viable biological substance can be substantially increased by maintaining the injector under vacuum after the drying or freeze-drying of the biological substance on the tines.
  • the biological substance may be freeze-dried on the tines by a process described in the aforementioned US. patents granted to me, and during the time that the injectors are in the vacuum chamber subsequent to the freeze-drying of the biological substance, the container materials may be applied thereto to insure the retention of a vacuum within the containers if the vacuumis desired to be retained.
  • the injectors carry a living biological substance
  • the injectors with the freeze-dried biological substance may be transported from the chamber for freeze-drying to a second vacuum chamber wherein the vacuum-packed hermetically sealed containers are applied thereto, which container may be made of plastic glass or metal foil.
  • an inoculation device which is smaller, lighter, easier to manufacture and easier to use than the inoculation devices heretofore provided.
  • the handles of the inoculation devices described in my previously-mentioned co-pending application are on the order of about 30 millimeters high and about millimeters in diameter, whereas the inoculation devices of the present invention have flat handles about 15 millimeters by 15 millimeters square and only about 1 to 2 millimeters thick.
  • the inoculation devices of the present invention may carry either living biological substances or non-living biological substances; however, if a living biological substance is used, then the injector must be vacuum-packed and hermetically sealed.
  • the injector so packaged may be introduced into a suitable container and thereafter hermetically sealed under vacuum to provide a predetermined shelf life for the injector. in such a case as this, several injectors packaged in plastic may be introduced into the same container for subsequent hermetic sealing thereof.
  • a transcutaneous injector comprising a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, and a one-piece handle integral with said top surface of said base plate and hingedly connected thereto, said one-piece handle having a reduced cross section adjacent to said top surface of said base plate, said one-piece handle being movable between a use position in which said one-piece handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said one-piece handle is substantially parallel to said base plate to facilitate the storage of said injecfor.
  • a prepared package for a transcutaneous injector comprising a container, a transcutaneous injector entirely disposed within said container, said injector including a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, said tines carrying a biological substance on the distal ends thereof, and a one-piece handle integral with said top surface of said base plate and hingedly connected thereto, said handle having a reduced cross section adjacent to said top surface of said bas plate, said one-piece handle being movable between a use position in which said one-piece handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said one-piece handle is substantially parallel to said base plate, said one-piece handle being in said storage position when said injector is disposed within said container, and means for maintaining said tines out of contact with said container when said injector is disposed within said container.
  • said base plate includes a pair of abutment surfaces positioned along opposed side edges of said base plate
  • said container includes a substantially rigid bottom portion having'a pair of shoulders carried by opposed side walls thereof, each of said shoulders being adapted to receive a respective one of said abutment surfaces, said shoulders being spaced from the bottom wall of said rigid bottom portion a distance greater than the distance between the distal end of said tines and said abutment surfaces, whereby to maintain said tines out of contact with said container when said injector is disposed within said container.
  • said means for maintaining said tines out of contact with said container include a substantially rigid U-shaped cover adapted to support said base plate, the bottom wall of said U-shaped cover being spaced apart in use from said base plate a distance greater than the length of said tines so as to maintain said tines out of contact with said container.
  • said means for maintaining said tines out of contact with said container include an annular member disposed within said container and adapted to receive said injector with the tines thereof disposed within said annular member.
  • a transcutaneous injector comprising an arcuate base plate having a concave top surface and a convex bottom surface, a plurality of tines carried by said convex bottom surface of said base plate and extending outwardly therefrom, and a one-piece handle integral with and hingedly connected to said concave top surface of said base plate and extending outwardly therefrom, said one-piece handle having a reduced cross section adjacent to said base plate, said one-piece handle being movable between a use position and a storage position,
  • said injector being adapted to be rolled against the skin to puncture the skin at a plurality of points and introduce a biological substance carried by said tines into the body.
  • a prepared package for a transcutaneous injector comprising a container, a transcutaneous injector entirely disposed within said container, said injector including a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, said tines carrying a biological substance on the distal ends thereof, and a handle hingedly connected to said top surface of said base plate, said handle being movable between a use position in which said handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said handle is substantially parallel to said base plate, said handle being in said storage position when said injector is disposed within said container, a substantially rigid U-shaped cover adapted to support said base plate, the bottom wall of said U-shaped cover being spaced apart in use from said base plate a distance greater than the length of said tines so as to maintain said tines out of contact with said container when said injector is disposed therewithin.

Abstract

A multiple puncture injector device for use in transcutaneous injection, the injector having a handle hingedly connected to the top surface of a base plate and movable between a use position in which the handle extends outwardly of the base plate and a storage position in which the handle is substantially parallel to the base plate to facilitate storage thereof; the base plates may be straight or arcuate; the handles may be locked in the use and storage positions. The injectors can be packaged in vacuum-packed hermetically sealed containers, which containers are connected one to another in end-to-end relationship to facilitate the detachment of a selected one of the packages.

Description

United States Patent Rosenthal 1 July 1 1, 1972 s41 MULTIPLE PUNCTURE INJECTOR FOREIGN PATENTS OR APPLICATIONS DEVICE 4,609 0/1915 Great Britain ..15/258 [72] Inventor: Sol Roy Rosenthal, 230 East Dela 1,309,352 10/1962 France ..128/253 Place, Chicago, Ill. 6061 l Primary Examiner-William T. Dixson, Jr. [22] 1970 Attorney-Prangley, Clayton, Mullin, Dithmar & Vogel [21] App1.No.: 8,625
[57] ABSTRACT [52] US. Cl ..206/63.4, 128/253 A multiple puncture injector device for use in transcutaneous [51] Int. Cl. ..A6lb 19/02, B65d 81/20 injection, the injector having a handle hingedly connected to [58] Field of Search ..206/63.4, 63.2, 56A, 56 AB; the top surface of a base plate and movable between a use 128/253, 333, 314, 329; 15/253 position in which the handle extends outwardly of the base plate and a storage position in which the handle is substan- I 56] References Cited tially parallel to the base plate to facilitate storage thereof; the base plates may be straight or arcuate; the handles may be UNITED STATES PATENTS locked in the use and storage positions. The injectors can be 3,289,670 12/1966 Krug et al packaged in vacuum-packed hermetically sealed containers, 3,131,410 1964 Anderson et a] which containers are connected one to another in end-to-end 3,444939 1969 "@1161 el relationship to facilitate the detachment of a selected one of 3,22 1 1 Rosenthal the packages 2,817,336 12/1957 Kravitz et al.... 3,070,102 12/1962 MacDonald ..206/56 A 20 China, 18 Drawing Figures PKTENTEDJUL H 1972 3, 675.76 6
SHEET 1 OF 3 SOL ROY ROSENTHAL BY PATENTEDJUL 11 I972 3. 675,766
swam 3 BF 3 IOOSb MULTIPLE PUNCTURE INJECTOR DEVICE This invention relates to a multiple puncture injector device for use in transcutaneous injection and more particularly to an injector with either a straight base or an arcuate base with a handle hingedly secured thereto to facilitate easy storage thereof.
An important object of the present invention is to provide a transcutaneous injector comprising a base plate having a top surface and a bottom surface, a plurality of tines carried by the bottom surface of the base plate extending outwardly therefrom and substantially normal thereto, and a handle hingedly connected to the top surface of the base plate, the handle being movable between a use position in which the handle is substantially normal to the base plate and extends outwardly therefrom and a storage position in which the handle is substantially parallel to the base plate to facilitate the storage ofthe injector.
Another object of the present invention is to provide a prepared package for an injector of the type set forth including a vacuum-packed hermetically sealed container disposed completely about the injector when the handle of the injector is in the storage position.
A further object of the present invention is to provide a series of prepared packages connected one to another in end-toend relationship, the connectionsbeing adapted easily to be broken to detach a selected one of the series of prepared packages without detaching the others of the series of prepared packages, each of the packages being of the type set forth with the containers thereof having connecting flanges extending outwardly therefrom.
A further object of the present invention is to provide a transcutaneous injector comprising an arcuate base plate having a concave top surface and a convex bottom surface, a plurality of tines carried by the convex bottom surface of the base plate and extending outwardly therefrom, and a handle connected to the concave top surface of the base plate and extending outwardly therefrom, the injector being adapted to be rolled against the skin to puncture the skin at a plurality of points and introduce a biological substance carried by the tines into the body.
A still further object of the present invention is to provide a prepared package for an injector with an arcuate base plate of the type set forth, the package including a vacuum-packed hermetically sealed container disposed completely about the injector when the handle of the injector is in the storage positron.
The invention, both as to its organization and method of operation, together with further objects and advantages thereof, will best be understood by reference to the following specification taken in connection with the accompanying drawings in which:
FIG. 1 is a view in vertical section of a transcutaneous injector incorporating therein features of the present invention;
FIG. 2 is a perspective view of a series of prepared packages for the injector of FIG. 1, one of the prepared packages having the cover off to show the inside arrangement thereof;
FIG. 3 is a side elevational view partly in vertical section of a series of prepared packages for the injector of FIG. 1;
FIG. 4 is a plan view of a portion of the series of prepared packages of FIG. 3;
FIG. 5 is a perspective view of an embodiment of a handle for the injector of FIG. 1;
FIG. 6 is a perspective view of an embodiment of a handle for the injector of FIG. 1;
FIG. 7 is a side elevational view of an injector having a fixed handle and an arcuate base;
FIG. 8 is a bottom view of the injector of FIG. 7;
FIG. 9 is a side elevational view of an injector having a hinged handle and an arcuate base;
FIG. 10 is a side elevational view partly in vertical section of a series of prepared packages for the injector of FIGS. 1;
FIG. 11 is a view in vertical section of the injector of FIG. 9 disposed within a vacuum-packed hermetically sealed container;
FIG. 12 is a side elevational view of a series of the packages of FIG. 11;
FIG. 13 is a plan view of an embodiment of the transcutaneous injector of FIG. 1;
FIG. 14 is a side elevational view of the injector of FIG. 13;
FIG. 15 is a view in vertical section of an injector mounted in a vacuum-packed hermetically sealed container;
FIG. 16 is a plan view of the container of FIG. 15 without the injector disposed therewithin;
FIG. 17 is a view in vertical section of a transcutaneous injector having means for locking the handle thereof in the use and storage positions thereof; and
FIG. 18 is a side elevational view partly broken away of the injector of FIG. 17.
Referring to FIG. 1, there is disclosed an injector having a substantially flat base plate 101, the base plate 101 including a top surface 102 anda bottom surface 103 spaced apart and parallel thereto. Extending upwardly, from opposed side edges of the bottom surface 102 are two spaced-apart and generally parallel abutment surfaces 104, each ofthe abutment surfaces 104 leading to a shoulder 105. generally parallel to the top surface 102. Two parallel spaced-apart grooves 106 are cut into the bottom surface 103 and extend for a predetermined distance from the bottom surface 103 toward the top surface 102, the grooves 106 being spaced apart a preselected distance to receive therein a metal plate 107 having upturned flanges 108, the flanges 108 being spaced apart a predetermined distance and being of a predetennined length securely to fit within the grooves 106. The metal plate 107 may be mounted in the base plate 101 in a variety of ways, the abovedescribed method being selected merely for purposes of illustration. Outwardly depending from and substantially normal to the metal plate 107 are a plurality of tines 1 10, the tines 1 10 carrying on the ends thereof distal from the metal plate 107 a biological substance 111.
The injector 100 is provided with a handle 115, the handle being connected to the topsurface 102 of the base plate 101 and positioned generally parallel to the side edges of the base plate 101, the handle 115 further including two spacedapart and parallel side walls 1 16 interconnected by a top wall 117 and two parallel spaced-apart end walls 118. The handle 115 is hingedly connected to the top surface 102 of the base plate 101 by a hinge 120, the hinge 120 being integral with the handle 115 and the base plate 101 and being of reduced cross section as compared to the handle 115. The handle 1 15 is movable between a use position, as shown in FIG. 1, in which the handle 115 is substantially normal to the base plate 101 and extends outwardly therefrom and a storage position in which the handle 115 is substantially parallel to the base plate 101 to facilitate the storage of the injector 100, all as hereinafter explained.
Referring now to FIG. 2, there is shown in the left-hand portion thereof the injector 100 in position to be packaged, the injector 100 being provided with a U-shaped cover 125, the U- shaped cover including two parallel spaced-apart side walls 126 interconnected by a bottom wall 127, the top edge of each of the side walls 126 forming an abutment surface 128. The side walls 126 of the U-shaped cover 125 are spaced apart a predetermined distance so as to receive thereon the shoulders 105 of the injector 100 and firmly to engage the abutment surfaces 104 of the injector 100 with the adjacent side wall 126 of the U-shaped cover 125. The vertical lengths of the side walls 126 are selected so as to position the bottom wall 127 of the U-shaped cover 125 away from the tines 110 and the biological substances 1 11 carried thereon when the injector 100 is positioned in use on the U-shaped cover 125, thereby to maintain the tines 110 out of contact with the container material as hereinafter explained.
There is further shown in the right-hand portion of FIG. 2 a container 130 for the combination of the injector 100 and the U-shaped cover 125, the container 130 including a top layer 131 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid. The top layer 131 has extending outwardly completely around the periphery thereof a top flange 132. The container 130 further includes a bottom layer 133 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid. The bottom layer 133 is disposed about the U-shaped cover 125 to substantially encircle the same and includes a bottom flange 134 extending completely around the periphery of the U-shaped cover 125, which flange 134 is substantially coextensive with the top flange 132. The top flange 132 and the bottom flange 134 are of the type of synthetic plastic resin which seals when heated, thereby to form a container 130 suitable for the storage of the injector 100 when the tines 110 thereof carry a non-living biological substance thereon, the container 130 being sealed after the injector 100 has been sterilized with ethylene oxide gas or by other means well known in the art. When the tines 110 of the injector 100 carry thereon a living biological substance, the injector 100 must be stored under vacuum and the container 130 must be hermetically sealed to prevent the biological substance from being contacted by air or moisture. To this end, the container 130 may be made from glass or a metal foil, as previously disclosed in my co-pending patent application entitled VACUUM-PACKED I-IERMETICALLY SEALED MULTI- PLE PUNCTURE DEVICE, filed on June 16, 1969, Ser. No. 833,299.
Intermediate adjacent containers 130, either the top flange 132 of the bottom flange 134 or both are scored as at 135 to provide connections between a series of prepared packages 140 connected one to another in end-to-end relationship, the connections therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 140 without detaching the others of the series of prepared packages.
There is further disclosed, as shown in FIG. 3, an injector 200 having a substantially flat base plate 201, the base plate 201 including a top surface 202 and a bottom surface 203 spaced apart and parallel thereto. Extending upwardly from opposed side edges of the bottom surface 202 are two spacedapart and generally parallel abutment surfaces 204 leading to a shoulder 205 generally parallel to the top surface 202. Two parallel spaced-apart grooves (not shown) are cut into the bottom surface 203 and extend for a predetermined distance from the bottom surface 203 toward the top surface 202, the grooves being spaced apart a preselected distance to receive therein a metal plate 207 having upturned flanges (not shown), the flanges being spaced apart a predetermined distance and of a predetermined length securely to fit within the grooves. Outwardly depending from and substantially normal to the metal plate 207 are a plurality of tines 210, the tines 210 carrying on the ends thereof distal from the metal plate 207 a biological substance 21 l.
The injector 200 is provided with a handle 215, the handle 215 being connected to the top surface 202 of the base plate 201 and positioned generally parallel to the side edges of the base plate 201, the handle 215 further including two spacedapart and parallel side walls 216 interconnected by a top wall 217 and two spaced-apart end walls 218. The handle 215 is hingedly connected to the top surface 202 of the base plate 201 by a hinge 220 being integral with the handle 215 and being of reduced cross section as compared to the handle 215. The handle 215 is movable between a use position, as shown in the left-hand portion of FIG. 3, in which the handle 215 is substantially normal to the base plate 201 and extends outwardly therefrom and a storage position, as shown in the middle portion of FIG. 3, in which the handle 215 is substantially parallel to the base plate 201 to facilitate the storage of the injector 200, all as hereinafter explained.
Referring now to the middle portion of FIG. 3', there is shown the injector 200 in position to be packaged in a container 230, the container 230 including a top layer 231 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid. The top layer 231 has extending outwardly completely around the periphery thereof, a top flange 232, see particularly FIG. 4. The container 230 further includes a bottom layer 233 of synthetic plastic resin which is rigid and retains its shape and rigidity when subjected to moderately elevated temperatures, the bottom layer 233 including two parallel spaced-apart side walls 236 interconnected by a bottom wall 237, the top edges of the side walls 236 being formed into shoulders 238. A bottom flange 234 extends outwardly completely around the periphery of the bottom layer 233, the bottom flanges 234 of adjacent containers 230 being connected and scored as at 235 to provide connections between a series of prepared packages 240 connected one to the other in end-to-end relationship, the connection therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 230 without detaching the others of the series of prepared packages.
The bottom layer 233 of the container 230 performs the same function as the U-shaped cover 125 previously described in that the side walls 236 and shoulders 238 thereon are spaced apart a predetermined distance so as to receive thereon the shoulders 205 of the injector 200 and firmly to engage the abutment surface 204 of the injector 200 with the adjacent side wall 236 of the bottom layer 233. The vertical lengths of the side walls 236 are selected so as to position the bottom wall 237 of the bottom layer 233 away from the tines 210 and the biological substance 21l carried thereby when the injector 200 is positioned within the container 230, thereby to maintain the tines 210 out of contact with the container 230. In lieu of the shoulders 238, an internal ridge (not shown) positioned on the bottom wall 237 of the bottom layer 233 of the container 230 may be used to support the injector 200 when the injector 200 is disposed within the container 230, thereby to maintain the tines 210 out of contact with the container 230. The container 230 herein may also be made impervious to air and moisture, i.e., hermetically sealed, for the storage of an injector 200 carrying on the tines 210 thereof a living biological substance, all as hereinbefore explained.
There is further disclosed, as shown in FIG. 10, an injector 300 having a substantially flat base plate 301, the base plate 301 including a top surface 302 and a bottom surface 303 spaced apart and parallel thereto. Extending upwardly from opposed side edges of the bottom surface 302 are two spacedapart and generally parallel abutment surfaces 304 leading to a shoulder 305 generally parallel to the top surface 302. Two parallel spaced-apart grooves (not shown) are cut into the bottom surface 303 and extend for a predetermined distance from the bottom surface 303 toward the top surface 302, the grooves being spaced apart a preselected distance to receive therein a metal plate 307 having upturned flanges (not shown), the flanges being spaced apart a predetermined distance and of a predetermined length securely to fit within the grooves. Outwardly depending from and substantially normal to the metal plate 307 are a plurality of tines 310, the tines 310 carrying on the ends thereof distal from the metal plate 307 a biological substance 31 1.
The injector 300 is provided with a handle 315, the handle 315 being connected to the top surface 302 of the base plate 301 and positioned generally parallel to the side edges of the base plate 301, the handle 315 further including two spacedapart and parallel side walls 316 interconnected by a top wall 317 and two spaced-apart end walls 318. The handle 315 is hingedly connected to the top surface 302 of the base plate 301 by a hinge 320 being integral with the handle 315 and Referring now to the middle portion of FIG. 10, there is shown the injector 300 in position to be packaged in a container 330, the container 330 including a top layer 331 of a rigid synthetic plastic resin having extending outwardly therefrom and completely around the periphery thereof a top flange 332. The container 330 further includes a bottom layer 333 of a rigid synthetic plastic resin, the bottom layer 333 including two parallel side walls 336 interconnected by a bottom wall 337. Spaced a preselected distance from the bottom wall 337 along each of the side walls 336 is a shoulder 338, the shoulders 338 being cut into the respective side walls 336 to provide a portion 339 of the side walls 336 extending above the shoulders 338 having a reduced thickness. The portions 339 of the side walls 336 extend upwardly and are formed into a bottom flange 334 extending completely around the periphery of the bottom layer 333, the bottom flanges 334 being substantially coextensive with the upper flanges 332 and being secured and scored as at 335 to provide connections between a series of prepared packages 340 connected one to the other in end-to-end relationship, the connections therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 340 without detaching the others of the series of prepared packages.
The side walls 336 and particularly the portions 339 having a reduced thickness are spaced apart a predetermined distance so as to receive therein and on the shoulders 338 formed thereby the shoulders 305 of the injector 300 and firmly to engage the abutment surfaces 304 of the injector 300 with the adjacent side walls 336 of the bottom layer 333 of the container 330. The lengths of the side walls 336 are selected so as to position the injector 300 completely within the vertical extent thereof when the handle 315 of the injector 300 is in the storage position thereof and to position the bottom wall 337 of the container 330 away from the tines 310 and the biological substances 311 carried thereon when the injector 300 is positioned for storage within the container 330, thereby to maintain the tines 310 out of contact with the container 330. The container 330 herein may also be made impervious to air and moisture, i.e., hermetically sealed, for the storage of an injector 300 carrying on the tines 310 thereof a living biological substance, all as hereinbefore explained.
With reference to FIGS. 7 and 8, there is disclosed an injector 400 having an arcuate base plate 401, the arcuate base plate 401 including a concave top surface 402and a convex bottom surface 403, the convex bottom surface 403- being spaced apart and generally parallel to the top surface 402. Extending diagonally upwardly from opposed side edges of the convex bottom surface 403 are two spaced-apart abutment surfaces 404, each of the abutment surfaces 404 leading to a shoulder 405, the shoulders 405 extending diagonally outwardly and away from the adjacent abutment surface 404 to form an inverted V therebetween. Two spaced-apart grooves 406 are cut into the convex bottom surface 403 extending toward the concave top surface 402, the grooves 406 being spaced apart a preselected distance to receive therein a metal plate 407 having upturned flanges 408, the flanges 408 being spaced apart a predetermined distance and being of a predetermined length securely to fit within the grooves 406. Outwardly depending from the metal plate 407 are a plurality of tines 410, the tines 410 carrying on the ends thereof distal from the metal plate 407 a biological substance 411.
The injector 400 is provided with a handle 415, the handle 415 being fixedly connected to the concave top surface 402 of the arcuate base plate 401 as at 420. The handle 415 forms a plane parallel to the direction in which the injector 400 is rolled to introduce the biological substance 411 on the distal ends of the tines 410 into a body, all as hereinafter explained.
With reference to FIG. 5, there is shown therein a portion of an injector 500, the injector 500 having a base plate 501 with a top surface 502. Disposed upon the top surface 502 of the injector 500 is a handle 515, the handle 515 being an alternate embodiment for the handle 415 for the injector 400 or being an alternate embodiment for the handle 115 of the injector 100. The handle 515 is hingedly connected as at 520 to the base plate 501, as hereinbefore described with reference to injectors 100, 200 and 300. The handle 515 includes two spaced-apart generally parallel side walls 516 interconnected by a pair of upstanding end walls 517 and a top wall 518. Each of the side walls 516 has a vertical portion 521 extending downwardly from the top wall 518, a lower arcuate portion 522 extending upwardly from the top surface 502 of the base plate 501 and an arcuate gripping section 523 intermediate the vertical portion 521 and the arcuate portion 522 and interconnecting the same to form a handle 515 easily gripped by the fingers to manipulate the injector 500.
With reference to FIG. 6, there is shown therein a portion of an injector 600, the injector 600 having a base plate 601 with a top surface 602. Disposed upon the top surface 602 of the injector 600 is a handle 615, the handle 615 being an alternate embodiment for the handle of the injector 100. The handle 615 is hingedly connected as at 620 to the base plate 601, the hinged connections 620 being spaced apart to allow the handle 615 to assume a storage position wherein the handle 615 is substantially parallel to the base plate 601. The handle 615 is S-shaped and includes two spaced-apart generally parallel side walls 616 interconnected by two spaced-apart end walls 617 and a top wall 618. The side walls 616 are complementary in shape and are formed of a right-hand curve as at 621 which leads to a left-hand curve as at 622, all as viewed in FIG. 6, to form a handle 615 easily gripped by the fingers to manipulate the injector 600.
With reference to FIGS. 9, 11 and 12, there is disclosed an injector 700 having an arcuate base plate 701, the arcuate base plate 701 including a concave top surface 702 and a convex bottom surface 703 being spaced apart and generally parallel to the top surface 702. Extending diagonally upwardly from opposed side edges of the convex bottom surface 703 are two spaced-apart abutment surfaces 704, each of the abutment surfaces 704 leading to a shoulder 705, the shoulders 705 extending diagonally outwardly and away from the adjacent abutment surface 704 to form an inverted *V therebetween. Two spaced-apart grooves (not shown) are cut into the convex bottom surface 703 extending toward the concave top surface 702, the grooves being spaced apart a preselected distance to receive therein a metal plate 707 having upturned flanges (not shown), the flanges being spaced apart a predetermined distance and being of a predetermined length securely to fit within the grooves. Outwardly depending from the metal plate 707 are a plurality of tines 710, the tines 710 carrying on the ends thereof distal from the metal plate 707 a biological substance 711.
The injector 700 is provided with a handle 715, the handle 715 being connected to the concave top surface 702 of the arcuate base plate 701 and including two spaced-apart arcuate and parallel side walls 716 interconnected by a top wall 717 and end walls 718. The handle 715 is hingedly connected to the concave top surface 702 of the arcuate base plate 701 adjacent one of the side edges thereof by a hinge 720, the hinge 720 being integral with the handle 715 and the arcuate base plate 701 and being of reduced cross section as compared to the handle 715. The handle 715 is movable between a use position (the solid line position in FIG. 9) in which the handle 715 is spaced from the arcuate base plate 701 and a storage position (the dotted line position in FIG. 9) in which the handle 715 is substantially parallel to the arcuate base plate 701 to facilitate the storage of the injector 700, all as hereinafter explained. The degree of curve of the side walls 716 of the handle 715 is selected so that the handle 715 securely fits adjacent to the concave top surface 702 of the arcuate base plate 701 when the handle 715 is in the storage position thereof.
Referring now to FIG. 1 1, there is shown the injector 700 in a container 730, the container 730 including a top layer 731 of synthetic plastic resin film of the type which, when applied to a solid surface and heated, molds itself into a shape conforming to the outer adjacent surface of the solid. The top layer 731 has extending outwardly completely around the periphery thereof a top flange 732. The container 730 further includes a bottom layer 733 of synthetic plastic resin which is rigid and retains its shape and rigid character when subjected to moderately elevated temperatures, the bottom layer 733 includes two parallel spaced-apart side walls 736 interconnected by a bottom wall 737, the top edge of the side walls 736 being formed into shoulders 738. A bottom flange 734 extends outwardly completely around the periphery of the bottom layer 733, the bottom flanges 734 of adjacent containers 730 being connected and scored as at 735 to provide connections between a series of prepared packages 740 connected one to the other in end-to-end relationship, the connections therebetween being adapted easily to be broken to detach a selected one of the series of prepared packages 740 without detaching the others of the series of prepared packages.
The bottom layer 733 of the hermetically sealed container 730 performs the same function as the U-shaped cover 125 previously described in that the side walls 736 and shoulders 738 thereon are spaced apart a predetermined distance so as to receive thereon the shoulders 705 of the injector 700 and firmly to engage the abutment surfaces 704 of the injector 700 with the adjacent side wall 736 of the bottom layer 733. The vertical lengths of the side walls 736 are selected so as to position the bottom wall 737 of the bottom layer 733 away from the tines 710 and the biological substance 711 carried thereby when the injector 700 is positioned in use within the container 730, thereby to maintain the tines 710 out of contact with the container 730. The container 730 herein may also be made impervious to air and moisture, i.e., hermetically sealed, for the storage of an injector 700 carrying on the tines 710 thereof a living biological substance, all as hereinbefore explained.
Referring to FIGS. 13 and 14, there is disclosed an injector 800 having a substantially flat base plate 801, the base plate 801 including a top surface 802 and a bottom surface 803 spaced apart and parallel thereto. Extending upwardly from opposed side edges of the bottom surface 802 are two spacedapart and generally parallel abutment surfaces 804. Two spaced-apart grooves 806 are cut into the bottom surface 803 and extend diagonally upwardly toward the top surface 802 for a predetermined distance from the bottom surface 803, the grooves 806 being spaced-apart a preselected distance to receive therein a metal plate 807 having diagonally upturned flanges 808, the flanges 808 being spaced-apart a predetermined distance and of a predetermined angle and being of a predetermined length securely to fit within the grooves 806. Outwardly depending from and substantially normal to the base plate 807 are a plurality of tines 810, the tines 810 carrying on the ends thereof distal from the metal plate 807 a biological substance 81 1.
The injector 800 is provided with a handle 815, the handle 815 being connected to the top surface 802 of the base plate 801 and positioned generally diagonally to the side edges of the base plate 801, Le, from comer to corner thereof, the handle 815 further including two spaced-apart and parallel side walls 816 interconnected by a top wall 817 and two spaced-apart end walls 818. The handle 815 is hingedly connected to the top surface 802 of the base plate 801 by a hinge 820, the hinge 820 being integral with the handle 815 and the base plate 801 and being of reduced cross section as compared to the handle 815. The handle 815 is movable between a use position in which the handle 815 is substantially normal to the base plate 801 and extends outwardly therefrom and a storage position in which the handle 815 is substantially paral lel to the base plate 801 to facilitate the storage of the injector 100. The diagonal positioning of the handle 815 is advantageous in that it provides for a better gripping surface when using the injector 800 for inoculation purposes.
Referring to FIGS. 15 and 16, there is disclosed an injector 900 similar in construction to the injector 100 with the metal plate 907 being mounted to the base plate 901 in a fashion similar to that disclosed in injector 800. It is seen, therefore, that the metal plate 900 carrying the tines 910 depending therefrom may be mounted to the base plate 901 by various methods, the particular method chosen herein being a matter of choice.
The injector 900 may optionally include two buttons or knobs 905 depending from the bottom surface 903 of the base plate 901 and spaced apart 180, the number of knobs 905 in excess of two and the angular placement thereof being a matter of choice. The injector 900 is provided with a handle 915, which handle 915 is of the same type as hereinbefore disclosed and may be positioned as shown, generally parallel to the side edges of the base plate 901 or positioned diagonally with respect thereto.
There is further disclosed a container 930, which container may be made of glass if the biological substance 911 carried by the tines 910 is a living substance to hermetically seal the same, the container 930 including a side wall 931 and a bottom wall 932, a top (not shown) is provided for the container 930, which top may be hermetically sealed to the side wall 931. Disposed within the container 930 is a spacer ring 935, the spacer ring 935 being generally annular in shape and having spaced at intervals around the periphery thereof beveled side spacers 936. The beveled side spacers 936 serve to position the spacer ring 935 within the container 930 and to position the injector 900 in registry over the spacer 935 when the injector 900 is introduced into the container 930, as hereinafter explained. The spacer ring 930 is further provided with knob or button receptacles 937 spaced in angular relationship corresponding to the angular relationship between the knobs or buttons 905 depending from the base plate 901 of the injector 900 and the number of buttons 905 which may be used. Upon introduction of the injector 900 into the container 930, the beveled side spacers 936 of the spacer ring 935 guide the injector 900 to a registry position above the spacer ring 935. Thereafter, the injector 900 is rotated until the knobs or buttons 905 are positioned above and fit within the receptacles 937, thereby to position the injector 900 in the storage condition thereof within the receptacle 937, it being noted that the vertical length of the spacer ring 935 is of sufficient distance to maintain the tines 910 out of contact with the container 930. Subsequent hermetic sealing of the container 930 under vacuum will provide for a substantial shelf life of the living biological substance 911 carried by the tines 910.
Referring now to FIGS. 17 and 18, there is disclosed therein an injector 1000 similar in construction to the injector 900 except that there is provided spaced apart and upwardly extending and generally parallel side walls 1004, each of the side walls 1004 carrying on the inside surface thereof two spacedapart button receptacles 1005 each positioned near a respective end of the side wall 1004 adjacent to the top wall 1002 of the base plate 1001. The handle 1015 is provided on each end wall 1018 thereof with a button 1019 adapted to fit within one of the receptacles 1005.
As shown in the drawings, when the handle 1015 is in the storage position thereof, the full-line position in FIG. 17 and the phantom-line position in FIG. 18, the buttons 1019 are positioned within their respective button receptacles 1005, thereby to lock the handle 1015 in the storage position thereof. When the handle 1015 is in the use position thereof, the phantom-line position in FIG. 17 and the full-line position in FIG. 18, the handle 1015 is maintained in position by the positioning of the handle of the user. It will be appreciated that the side walls 1004 of the injector 1000 are made of resilient material, thereby to permit dislodgement of the buttons 1019 from the respective receptacles 1005 therefor in order to move the handle 1015 from the use position thereof to the storage position thereof, the side walls 1004 having a vertical extent about the distance above the base plate 1002 as the handle 1015 is in the storage position thereof. It is further pointed out that the upwardly extending side walls 1004 are but one means for locking the handle 1015 in the desired position thereof, it being understood that other friction members may be used to accomplish the same purpose and it is intended that the above-illustrated means is but one illustration of locking means for the hinged handle of the present invention.
Further constructional details and the operation of the device will now be described. The metal plates hereinbefore described are relatively thin, about 0.025 millimeters thick and have depending therefrom relatively short tines about 2 millimeters in length, the tines being spaced apart from about 2 to millimeters, depending on the type of innoculation to be performed, the tines being spaced from the edge of the base plate about 1.5 to about 3.5 millimeters. Generally, the biological substance is applied to the distal l millimeter of the tines and thereafter dried or freeze-dried. The biological substance is introduced into the body through the skin when the injector and the tines are pressed by a person holding the injector against the skin. The inoculation with a multiple puncture disc having a substantially flat base plate of the type illustrated in FIGS. 1 to 4 and 10 herein, is well known in the art and these devices, in general, are the subject of US. Pat. Nos. 2,619,962; 3,072,122; 3,221,739 and 3,221,740, all issued to The biological substance placed on the tines may be chosen from a living virus such as small pox, measles, yellow fever, rabies, influenza, mumps or german measles; a living bacteria such as bacillus Calmette and Guerin (BCG), H37Ra (human attenuated tubercle bacilli); a non-living substance for skin testing for tuberculins, histoplamims, coccidioidins, sensitins in general or allergens; or a non-living substance for vaccinating for typhoid, paratyphoid, cholera or pertussis. Particularly where the biological substance is a living or visible bacteria or virus, prolonged contact with air or moisture is detrimental and the shelf life of any of the injectors described herein carrying a viable biological substance can be substantially increased by maintaining the injector under vacuum after the drying or freeze-drying of the biological substance on the tines.
The biological substance may be freeze-dried on the tines by a process described in the aforementioned US. patents granted to me, and during the time that the injectors are in the vacuum chamber subsequent to the freeze-drying of the biological substance, the container materials may be applied thereto to insure the retention of a vacuum within the containers if the vacuumis desired to be retained. Alternately, and particularly where the injectors carry a living biological substance,- the injectors with the freeze-dried biological substance may be transported from the chamber for freeze-drying to a second vacuum chamber wherein the vacuum-packed hermetically sealed containers are applied thereto, which container may be made of plastic glass or metal foil.
As may be seen, there has been provided an inoculation device which is smaller, lighter, easier to manufacture and easier to use than the inoculation devices heretofore provided. For instance, the handles of the inoculation devices described in my previously-mentioned co-pending application are on the order of about 30 millimeters high and about millimeters in diameter, whereas the inoculation devices of the present invention have flat handles about 15 millimeters by 15 millimeters square and only about 1 to 2 millimeters thick. The inoculation devices of the present invention may carry either living biological substances or non-living biological substances; however, if a living biological substance is used, then the injector must be vacuum-packed and hermetically sealed. Even in the case where a synthetic plastic material is used to package an injector carrying a life biological substance, the injector so packaged may be introduced into a suitable container and thereafter hermetically sealed under vacuum to provide a predetermined shelf life for the injector. in such a case as this, several injectors packaged in plastic may be introduced into the same container for subsequent hermetic sealing thereof.
In view of the foregoing, it is apparent that there has been provided an injector device for use in transcutaneous injections and package therefor, while there has been described what is at present considered to be the preferred embodiment of the invention, it will be understood that various modifications may be made therein and it is intended to cover in the appended claims all such modifications as fall within the true spirit and scope of the invention.
What is claimed is:
l. A transcutaneous injector comprising a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, and a one-piece handle integral with said top surface of said base plate and hingedly connected thereto, said one-piece handle having a reduced cross section adjacent to said top surface of said base plate, said one-piece handle being movable between a use position in which said one-piece handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said one-piece handle is substantially parallel to said base plate to facilitate the storage of said injecfor.
2. The transcutaneous injector set forth in claim 1, wherein said base plate and said handle are formed of a synthetic plastic resin.
3. The transcutaneous injector set forth in claim 1, wherein said tines are formed from a metal plate carried by said base plate.
4. The transcutaneous injector set forth in claim 1, wherein said handle is integral with said base plate.
5. The transcutaneous injector set forth in claim 1, wherein said handle is rectangular in shape, and hinged to said base plate along the entire length of said handle.
6. The transcutaneous injector set forth in claim 1, wherein said handle is S-shaped, thereby to provide opposed gripping surfaces on the side walls thereof.
7. The transcutaneous injector set forth in claim 1, wherein said handle is positioned diagonally along said top surface of said base plate.
8. The transcutaneous injector set forth in claim 1, wherein said handle is positioned parallel to opposed side edges of said base plate.
9. A prepared package for a transcutaneous injector comprising a container, a transcutaneous injector entirely disposed within said container, said injector including a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, said tines carrying a biological substance on the distal ends thereof, and a one-piece handle integral with said top surface of said base plate and hingedly connected thereto, said handle having a reduced cross section adjacent to said top surface of said bas plate, said one-piece handle being movable between a use position in which said one-piece handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said one-piece handle is substantially parallel to said base plate, said one-piece handle being in said storage position when said injector is disposed within said container, and means for maintaining said tines out of contact with said container when said injector is disposed within said container.
10. The prepared package set forth in claim 9, wherein said container includes a substantially rigid bottom portion adapted to house said injector therein to maintain said tines out of contact with said substantially rigid bottom portion.
11. The prepared package set forth in claim 9, wherein said base plate includes a pair of abutment surfaces positioned along opposed side edges of said base plate, and said container includes a substantially rigid bottom portion having'a pair of shoulders carried by opposed side walls thereof, each of said shoulders being adapted to receive a respective one of said abutment surfaces, said shoulders being spaced from the bottom wall of said rigid bottom portion a distance greater than the distance between the distal end of said tines and said abutment surfaces, whereby to maintain said tines out of contact with said container when said injector is disposed within said container.
12. The prepared package set forth in claim 9, wherein said means for maintaining said tines out of contact with said container include a substantially rigid U-shaped cover adapted to support said base plate, the bottom wall of said U-shaped cover being spaced apart in use from said base plate a distance greater than the length of said tines so as to maintain said tines out of contact with said container.
13. The prepared package set forth in claim 9, wherein said means for maintaining said tines out of contact with said container include an annular member disposed within said container and adapted to receive said injector with the tines thereof disposed within said annular member.
14. The prepared package set forth in claim 9, wherein said container is vacuum-packed and hermetically sealed.
15. The prepared package set forth in claim 9, wherein said container is a vacuum-packed hermetically sealed metal foil.
16. The prepared package set forth in claim 9, wherein said package is connected to another of said prepared package in end-to-end relationship, said connection being adapted easily to be broken to detach a selected one of said prepared packages.
17. The prepared package set forth in claim 9, wherein said package is vacuum-packed and hermetically sealed and connected to another of said vacuum-packed hermetically sealed prepared package in end-to-end relationship, said connection being adapted easily to be broken to detach a selected one of said prepared packages.
18. A transcutaneous injector comprising an arcuate base plate having a concave top surface and a convex bottom surface, a plurality of tines carried by said convex bottom surface of said base plate and extending outwardly therefrom, and a one-piece handle integral with and hingedly connected to said concave top surface of said base plate and extending outwardly therefrom, said one-piece handle having a reduced cross section adjacent to said base plate, said one-piece handle being movable between a use position and a storage position,
said injector being adapted to be rolled against the skin to puncture the skin at a plurality of points and introduce a biological substance carried by said tines into the body.
19. The transcutaneous injector set forth in claim 18, wherein said handle is fixedly connected to said concave top surface of said base plate and forms a plane substantially parallel to the direction said injector is rolled when introducing the biological substance into the body.
20. A prepared package for a transcutaneous injector comprising a container, a transcutaneous injector entirely disposed within said container, said injector including a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, said tines carrying a biological substance on the distal ends thereof, and a handle hingedly connected to said top surface of said base plate, said handle being movable between a use position in which said handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said handle is substantially parallel to said base plate, said handle being in said storage position when said injector is disposed within said container, a substantially rigid U-shaped cover adapted to support said base plate, the bottom wall of said U-shaped cover being spaced apart in use from said base plate a distance greater than the length of said tines so as to maintain said tines out of contact with said container when said injector is disposed therewithin.

Claims (20)

1. A transcutaneous injector comprising a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, and a one-piece handle integral with said top surface of said base plate and hingedly connected thereto, said one-piece handle having a reduced cross section adjacent to said top surface of said base plate, said one-piece handle being movable between a use position in which said one-piece handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said one-piece handle is substantially parallel to said base plate to facilitate the storage of said injector.
2. The transcutaneous injector set forth in claim 1, wherein said base plate and said handle are formed of a synthetic plastic resin.
3. The transcutaneous injector set forth in claim 1, wherein said tines are formed from a metal plate carried by said base plate.
4. The transcutaneous injector set forth in claim 1, wherein said handle is integral with said base plate.
5. The transcutaneous injector set forth in claim 1, wherein said handle is rectangular in shape, and hinged to said base plate along the entire length of said handle.
6. The transcutaneous injector set forth in claim 1, wherein said handle is S-shaped, thereby to provide opposed gripping surfaces on the side walls thereof.
7. The transcutaneous injector set forth in claim 1, wherein said handle is positioned diagonally along said top surface of said base plate.
8. The transcutaneous injector set forth in claim 1, wherein said handle is positioned parallel to opposed side edges of said base plate.
9. A prepared package for a transcutaneous injector comprising a container, a transcutaneous injector entirely disposed within said container, said injector including a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, said tines carrying a biological substance on the distal ends thereof, and a one-piece handle integral with said top surface of said base plate and hingedly connected thereto, said handle having a reduced cross section adjacent to said top surface of said base plate, said one-piece handle being movable between a use position in which said one-piece handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said one-piece handle is substantially parallel to said base plate, said one-piece handle being in said storage position when said injector is disposed within said container, and means for maintaining said tines out of contact with said container when said injector is disposed within said container.
10. The prepared package set forth in claim 9, wherein said container includes a substantially rigid bottom portion adapted to house said injector therein to maintain said tines out of contact with said substantially rigid bottom portion.
11. The prepared package set forth in claim 9, wherein said base plate includes a pair of abutment surfaces positioned along opposed side edges of said base plate, and said container includes a substantially rigid bottom portion having a pair of shoulders carried by opposed side walls thereof, each of said shoulders being adapted to receive a respective one of said abutment surfaces, said shoulders being spaced from the bottom wall of said rigid bottom portion a distance greater than the distance between the distal end of said tines and said abutment surfaces, whereby to maintain said tines out of contact with said container when said injector is disposed within said container.
12. The prepared package set forth in claim 9, wherein said means for maintaining said tines out of contact with said container include a substantially rigid U-shaped cover adapted to support said base plate, the bottom wall of said U-shaped cover being spaced apart in use from said base plate a distance greater than the length of said tines so as to maintain said tines out of contact with said container.
13. The prepared package set forth in claim 9, wherein said means for maintaining said tines out of contact with said container include an annular member disposed within said container and adapted to receive said injector with the tines thereof disposed within said annular member.
14. The prepared package set forth in claim 9, wherein said container is vacuum-packed and hermetically sealed.
15. The prepared package set forth in claim 9, wherein said container is a vacuum-packed hermetically sealed metal foil.
16. The prepared package set forth in claim 9, wherein said package is connected to another of said prepared package in end-to-end relationship, said connection being adapted easily to be broken to detach a selected one of said prepared packages.
17. The prepared package set forth in claim 9, wherein said package is vacuum-packed and hermetically sealed and connected to another of said vacuum-packed hermetically sealed prepared package in end-to-end relationship, said connection being adapted easily to be broken to detach a selected one of said prepared packages.
18. A transcutaneous injector comprising an arcuate base plate having a concave top surface and a convex bottom surface, a plurality of tines carried by said convex bottom surface of said base plate and extending outwardly therefrom, and a one-piece handle integral with and hingedly connected to said concave top surface of said base plate and extending outwardly therefrom, said one-piece handle having a reduced cross section adjacent to said base plate, said one-piece handle being movable between a use position and a storage position, said injector being adapted to be rolled against the skin to puncture the skin at a plurality of points and introduce a biological substance carried by said tines into the body.
19. The transcutaneous injector set forth in claim 18, wherein said handle is fixedly connected to said concave top surface of said base plate and forms a plane substantially parallel to the direction said injector is rolled when introducing the biological substance into the body.
20. A prepared package for a transcutaneous injector comprising a container, a transcutaneous injector entirely disposed within said container, said injector including a base plate having a top surface and a bottom surface, a plurality of tines carried by said bottom surface of said base plate extending outwardly therefrom and substantially normal thereto, said tines carrying a biological substance on the distal ends thereof, and a handle hingedly connected to said top surface of said base plate, said handle being movable between a use position in which said handle is substantially normal to said base plate and extends outwardly therefrom and a storage position in which said handle is substantially parallel to said base plate, said handle being in said storage position when said injector is disposed within said container, a substantially rigid U-shaped cover adapted to support said base plate, the bottom wall of said U-shaped cover being spaced apart in use from said base plate a distance greater than the length of said tines so as to maintain said tines out of contact with said container when said injector is disposed therewithin.
US8625A 1970-02-04 1970-02-04 Multiple puncture injector device Expired - Lifetime US3675766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US862570A 1970-02-04 1970-02-04

Publications (1)

Publication Number Publication Date
US3675766A true US3675766A (en) 1972-07-11

Family

ID=21732685

Family Applications (1)

Application Number Title Priority Date Filing Date
US8625A Expired - Lifetime US3675766A (en) 1970-02-04 1970-02-04 Multiple puncture injector device

Country Status (5)

Country Link
US (1) US3675766A (en)
JP (1) JPS513154B1 (en)
DE (1) DE2105882A1 (en)
FR (1) FR2078137A5 (en)
GB (1) GB1322294A (en)

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2474856A1 (en) * 1980-01-31 1981-08-07 Merieux Inst SCARIFIER DEVICE
US4292979A (en) * 1979-04-09 1981-10-06 Inglefield Jr Joseph T Allergy testing apparatus
US5487726A (en) * 1994-06-16 1996-01-30 Ryder International Corporation Vaccine applicator system
WO1996037155A1 (en) * 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical device and method for enhancing delivery of compounds through the skin
US5983136A (en) * 1996-09-17 1999-11-09 Deka Products Limited Partnership System for delivery of drugs by transport
US6083196A (en) * 1997-12-11 2000-07-04 Alza Corporation Device for enhancing transdermal agent flux
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
US6322808B1 (en) 1997-12-11 2001-11-27 Alza Corporation Device for enhancing transdermal agent flux
US6334856B1 (en) 1998-06-10 2002-01-01 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US20020016562A1 (en) * 1996-06-18 2002-02-07 Michel J. N. Cormier Device and method for enhancing transdermal flux of agents being delivered or sampled
US20020082543A1 (en) * 2000-12-14 2002-06-27 Jung-Hwan Park Microneedle devices and production thereof
US20020138049A1 (en) * 1998-06-10 2002-09-26 Allen Mark G. Microneedle devices and methods of manufacture and use thereof
EP1301238A1 (en) 2000-07-21 2003-04-16 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccines
US20030095582A1 (en) * 2000-12-21 2003-05-22 Ackley Donald E. Microneedle array systems
US20030135201A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Microneedle with membrane
US20030135167A1 (en) * 2001-09-19 2003-07-17 Gonnelli Robert R. Microneedles, microneedle arrays, and systems and methods relating to same
US20030135158A1 (en) * 2001-09-21 2003-07-17 Gonnelli Robert R. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US20030135166A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Switchable microneedle arrays and systems and methods relating to same
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
EP1383571A2 (en) 2001-04-20 2004-01-28 Alza Corporation Microprojection array immunization patch and method
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US20040236271A1 (en) * 1997-12-10 2004-11-25 Felix Theeuwes Device and method for enhancing transdermal agent flux
US20050171567A1 (en) * 2004-01-29 2005-08-04 Dehart Damon H. Lancet and method of manufacturing the same
US20050187521A1 (en) * 2002-01-15 2005-08-25 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20050261632A1 (en) * 2004-05-18 2005-11-24 Bai Xu High-Aspect-Ratio Microdevices and Methods for Transdermal Delivery and Sampling of Active Substances
US20060129174A1 (en) * 2000-10-16 2006-06-15 Corium International, Inc. Microstructures for delivering a composition cutaneously to skin
US20070060867A1 (en) * 2005-05-18 2007-03-15 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US7195122B2 (en) 2000-05-12 2007-03-27 Pall Corporation Filters
US20070083151A1 (en) * 2003-12-29 2007-04-12 Carter Chad J Medical devices and kits including same
US20070233011A1 (en) * 2006-03-13 2007-10-04 Kei Hagino Micropore forming system, micropore forming device, chip container, and chip container kit
US20070299361A1 (en) * 2006-06-08 2007-12-27 Lincoln Diagnostics, Inc. Skin testing-device system
US20080039805A1 (en) * 2004-06-10 2008-02-14 Frederickson Franklyn L Patch Application Device and Kit
US20080051695A1 (en) * 2005-05-18 2008-02-28 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US7338599B2 (en) 2000-05-12 2008-03-04 Pall Corporation Filtration systems and fitting arrangements for filtration systems
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US20080102192A1 (en) * 2004-11-18 2008-05-01 Johnson Peter R Masking Method for Coating a Microneedle Array
US20080195035A1 (en) * 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US20090198189A1 (en) * 2006-04-20 2009-08-06 3M Innovative Properties Company Device for applying a microneedle array
US20100222743A1 (en) * 2005-06-27 2010-09-02 Frederickson Franklyn L Microneedle array applicator device and method of array application
US7914480B2 (en) 2004-03-24 2011-03-29 Corium International, Inc. Transdermal delivery device
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
US8267889B2 (en) 2004-11-18 2012-09-18 3M Innovative Properties Company Low-profile microneedle array applicator
US8414959B2 (en) 2004-11-18 2013-04-09 3M Innovative Properties Company Method of contact coating a microneedle array
US8702726B2 (en) 2000-10-16 2014-04-22 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US8821446B2 (en) 2007-01-22 2014-09-02 Corium International, Inc. Applicators for microneedles
WO2014159235A1 (en) * 2013-03-14 2014-10-02 Becton, Dickinson And Company Continuous glucose monitoring on-body sensor
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
US9114238B2 (en) 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US9174035B2 (en) 2004-11-18 2015-11-03 3M Innovative Properties Company Microneedle array applicator and retainer
US20160030114A1 (en) * 2013-03-15 2016-02-04 The Research Institute At Nationwide Children's Hospital Medical testing apparatus and method of use
US9687641B2 (en) 2010-05-04 2017-06-27 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
WO2018035377A1 (en) 2016-08-17 2018-02-22 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
US9962534B2 (en) 2013-03-15 2018-05-08 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US10035008B2 (en) 2005-04-07 2018-07-31 3M Innovative Properties Company System and method for tool feedback sensing
US10195409B2 (en) 2013-03-15 2019-02-05 Corium International, Inc. Multiple impact microprojection applicators and methods of use
WO2019030238A1 (en) 2017-08-08 2019-02-14 Isabelle GROZELIER Surface cutting device, in particular for allergy diagnosis
US10245422B2 (en) 2013-03-12 2019-04-02 Corium International, Inc. Microprojection applicators and methods of use
US10384046B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
EP3543339A1 (en) 2015-02-13 2019-09-25 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
US10525246B2 (en) 2006-12-22 2020-01-07 Nanomed Skincare, Inc. Microdevice and method for transdermal delivery and sampling of active substances
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11052231B2 (en) 2012-12-21 2021-07-06 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
US11278678B2 (en) 2016-05-31 2022-03-22 Ndm Technologies Limited In or related to transdermal delivery

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483348A (en) * 1982-03-25 1984-11-20 Nathan Sher Skin testing device
CA2594291C (en) * 2004-12-28 2012-03-06 Nabtesco Corporation Skin needle manufacturing apparatus and skin needle manufacturing method

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191504609A (en) * 1915-03-24 1915-08-19 Charles Bainbridge Prest A New Pad for use in Applying Polishes and the like.
US2817336A (en) * 1952-12-20 1957-12-24 Kravitz Harvey Means for vaccinating
FR1309352A (en) * 1961-10-03 1962-11-16 New device to perform vaccination or medical tests
US3070102A (en) * 1960-05-12 1962-12-25 Harold B Macdonald Throw-away toothbrush and package
US3131410A (en) * 1963-04-12 1964-05-05 Johnson & Son Inc S C Novel polish combination
US3221739A (en) * 1962-03-26 1965-12-07 Rosenthal Sol Roy Injection device
US3289670A (en) * 1964-03-09 1966-12-06 Milo Bundy Corp Device for abrading and applying biologicals to the skin of a patient
US3444989A (en) * 1967-01-05 1969-05-20 Behringwerke Ag Casing for devices for intradermal application

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191504609A (en) * 1915-03-24 1915-08-19 Charles Bainbridge Prest A New Pad for use in Applying Polishes and the like.
US2817336A (en) * 1952-12-20 1957-12-24 Kravitz Harvey Means for vaccinating
US3070102A (en) * 1960-05-12 1962-12-25 Harold B Macdonald Throw-away toothbrush and package
FR1309352A (en) * 1961-10-03 1962-11-16 New device to perform vaccination or medical tests
US3221739A (en) * 1962-03-26 1965-12-07 Rosenthal Sol Roy Injection device
US3131410A (en) * 1963-04-12 1964-05-05 Johnson & Son Inc S C Novel polish combination
US3289670A (en) * 1964-03-09 1966-12-06 Milo Bundy Corp Device for abrading and applying biologicals to the skin of a patient
US3444989A (en) * 1967-01-05 1969-05-20 Behringwerke Ag Casing for devices for intradermal application

Cited By (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292979A (en) * 1979-04-09 1981-10-06 Inglefield Jr Joseph T Allergy testing apparatus
FR2474856A1 (en) * 1980-01-31 1981-08-07 Merieux Inst SCARIFIER DEVICE
US4453926A (en) * 1980-01-31 1984-06-12 Institut Merieux, Societe Anonyme Scarifier
US5487726A (en) * 1994-06-16 1996-01-30 Ryder International Corporation Vaccine applicator system
WO1996037155A1 (en) * 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical device and method for enhancing delivery of compounds through the skin
US7184826B2 (en) 1996-06-18 2007-02-27 Alza Corporation Device and method for enhancing transdermal flux of agents being delivered or sampled
US20020016562A1 (en) * 1996-06-18 2002-02-07 Michel J. N. Cormier Device and method for enhancing transdermal flux of agents being delivered or sampled
US20070118070A1 (en) * 1996-06-18 2007-05-24 Cormier Michel J Device with anchoring elements for transdermal delivery or sampling of agents
US5983136A (en) * 1996-09-17 1999-11-09 Deka Products Limited Partnership System for delivery of drugs by transport
US20040236271A1 (en) * 1997-12-10 2004-11-25 Felix Theeuwes Device and method for enhancing transdermal agent flux
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
US6322808B1 (en) 1997-12-11 2001-11-27 Alza Corporation Device for enhancing transdermal agent flux
US6083196A (en) * 1997-12-11 2000-07-04 Alza Corporation Device for enhancing transdermal agent flux
US6953589B1 (en) 1997-12-11 2005-10-11 Alza Corporation Device for enhancing transdermal agent flux
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
US6334856B1 (en) 1998-06-10 2002-01-01 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US20100312191A1 (en) * 1998-06-10 2010-12-09 Georgia Tech Research Corporation Microneedle Devices and Methods of Manufacture and Use Thereof
US20020138049A1 (en) * 1998-06-10 2002-09-26 Allen Mark G. Microneedle devices and methods of manufacture and use thereof
US8708966B2 (en) 1998-06-10 2014-04-29 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US7226439B2 (en) 1999-06-04 2007-06-05 Georgia Tech Research Corporation Microneedle drug delivery device
US20070225676A1 (en) * 1999-06-04 2007-09-27 Prausnitz Mark R Microneedle drug delivery device
US8257324B2 (en) 1999-06-04 2012-09-04 Georgia Tech Research Corporation Microneedle drug delivery device
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US7195122B2 (en) 2000-05-12 2007-03-27 Pall Corporation Filters
US7338599B2 (en) 2000-05-12 2008-03-04 Pall Corporation Filtration systems and fitting arrangements for filtration systems
US20050197308A1 (en) * 2000-07-21 2005-09-08 Smithkline Beecham Biologicals S.A. Vaccines
EP1301238A1 (en) 2000-07-21 2003-04-16 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccines
US8216190B2 (en) 2000-10-16 2012-07-10 Corium International, Inc. Microstructures for delivering a composition cutaneously to skin
US20060129174A1 (en) * 2000-10-16 2006-06-15 Corium International, Inc. Microstructures for delivering a composition cutaneously to skin
US8702726B2 (en) 2000-10-16 2014-04-22 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
US20020082543A1 (en) * 2000-12-14 2002-06-27 Jung-Hwan Park Microneedle devices and production thereof
US7027478B2 (en) 2000-12-21 2006-04-11 Biovalve Technologies, Inc. Microneedle array systems
US20030095582A1 (en) * 2000-12-21 2003-05-22 Ackley Donald E. Microneedle array systems
EP1383571A2 (en) 2001-04-20 2004-01-28 Alza Corporation Microprojection array immunization patch and method
US8361037B2 (en) 2001-09-19 2013-01-29 Valeritas, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
US20030135167A1 (en) * 2001-09-19 2003-07-17 Gonnelli Robert R. Microneedles, microneedle arrays, and systems and methods relating to same
US20030135158A1 (en) * 2001-09-21 2003-07-17 Gonnelli Robert R. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US8920375B2 (en) 2001-09-21 2014-12-30 Valeritas, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US20030135201A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Microneedle with membrane
US20030135166A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Switchable microneedle arrays and systems and methods relating to same
US20090062752A1 (en) * 2001-09-28 2009-03-05 Gonnelli Robert R Switchcable microneedle arrays and systems and methods relating to same
US20050137536A1 (en) * 2001-09-28 2005-06-23 Gonnelli Robert R. Microneedle with membrane
US20090043250A1 (en) * 2001-09-28 2009-02-12 Gonnelli Robert R Microneedle with membrane
US20050187521A1 (en) * 2002-01-15 2005-08-25 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
US20070083151A1 (en) * 2003-12-29 2007-04-12 Carter Chad J Medical devices and kits including same
US20050171567A1 (en) * 2004-01-29 2005-08-04 Dehart Damon H. Lancet and method of manufacturing the same
US7914480B2 (en) 2004-03-24 2011-03-29 Corium International, Inc. Transdermal delivery device
US20050261632A1 (en) * 2004-05-18 2005-11-24 Bai Xu High-Aspect-Ratio Microdevices and Methods for Transdermal Delivery and Sampling of Active Substances
US7591806B2 (en) 2004-05-18 2009-09-22 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US20080039805A1 (en) * 2004-06-10 2008-02-14 Frederickson Franklyn L Patch Application Device and Kit
US8758298B2 (en) 2004-11-18 2014-06-24 3M Innovative Properties Company Low-profile microneedle array applicator
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
US8741377B2 (en) 2004-11-18 2014-06-03 3M Innovative Properties Company Method of contact coating a microneedle array
US7846488B2 (en) 2004-11-18 2010-12-07 3M Innovative Properties Company Masking method for coating a microneedle array
US9174035B2 (en) 2004-11-18 2015-11-03 3M Innovative Properties Company Microneedle array applicator and retainer
US8414959B2 (en) 2004-11-18 2013-04-09 3M Innovative Properties Company Method of contact coating a microneedle array
US20080102192A1 (en) * 2004-11-18 2008-05-01 Johnson Peter R Masking Method for Coating a Microneedle Array
US8267889B2 (en) 2004-11-18 2012-09-18 3M Innovative Properties Company Low-profile microneedle array applicator
US10035008B2 (en) 2005-04-07 2018-07-31 3M Innovative Properties Company System and method for tool feedback sensing
US8043250B2 (en) 2005-05-18 2011-10-25 Nanomed Devices, Inc. High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US20070060867A1 (en) * 2005-05-18 2007-03-15 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US20080051695A1 (en) * 2005-05-18 2008-02-28 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US8048017B2 (en) 2005-05-18 2011-11-01 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US10315021B2 (en) 2005-06-24 2019-06-11 3M Innovative Properties Company Collapsible patch and method of application
US20080195035A1 (en) * 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
US20100222743A1 (en) * 2005-06-27 2010-09-02 Frederickson Franklyn L Microneedle array applicator device and method of array application
US8784363B2 (en) 2005-06-27 2014-07-22 3M Innovative Properties Company Microneedle array applicator device and method of array application
US9789249B2 (en) 2005-06-27 2017-10-17 3M Innovative Properties Company Microneedle array applicator device and method of array application
US7806266B2 (en) * 2006-03-13 2010-10-05 Sysmex Corporation Micropore forming system, micropore forming device, chip container, and chip container kit
US20070233011A1 (en) * 2006-03-13 2007-10-04 Kei Hagino Micropore forming system, micropore forming device, chip container, and chip container kit
US20090198189A1 (en) * 2006-04-20 2009-08-06 3M Innovative Properties Company Device for applying a microneedle array
US9119945B2 (en) 2006-04-20 2015-09-01 3M Innovative Properties Company Device for applying a microneedle array
US7922672B2 (en) 2006-06-08 2011-04-12 Lincoln Diagnostics, Inc. Skin testing-device system
US7631765B2 (en) 2006-06-08 2009-12-15 Lincoln Diagnostics, Inc. Skin testing-device system
US20070299361A1 (en) * 2006-06-08 2007-12-27 Lincoln Diagnostics, Inc. Skin testing-device system
US20080073242A1 (en) * 2006-06-08 2008-03-27 Lincoln Diagnostics, Inc. Skin Testing-Device System
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US10525246B2 (en) 2006-12-22 2020-01-07 Nanomed Skincare, Inc. Microdevice and method for transdermal delivery and sampling of active substances
US8821446B2 (en) 2007-01-22 2014-09-02 Corium International, Inc. Applicators for microneedles
US10238848B2 (en) 2007-04-16 2019-03-26 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US9114238B2 (en) 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US9452280B2 (en) 2007-04-16 2016-09-27 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US9498524B2 (en) 2007-04-16 2016-11-22 Corium International, Inc. Method of vaccine delivery via microneedle arrays
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
US9687641B2 (en) 2010-05-04 2017-06-27 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
US11419816B2 (en) 2010-05-04 2022-08-23 Corium, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
US11052231B2 (en) 2012-12-21 2021-07-06 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
US11110259B2 (en) 2013-03-12 2021-09-07 Corium, Inc. Microprojection applicators and methods of use
US10245422B2 (en) 2013-03-12 2019-04-02 Corium International, Inc. Microprojection applicators and methods of use
US10357191B2 (en) 2013-03-14 2019-07-23 Becton, Dickinson And Company Continuous glucose monitoring on-body sensor
WO2014159235A1 (en) * 2013-03-14 2014-10-02 Becton, Dickinson And Company Continuous glucose monitoring on-body sensor
JP2019134947A (en) * 2013-03-14 2019-08-15 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Continuous glucose monitoring on-body sensor
JP2016516472A (en) * 2013-03-14 2016-06-09 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Continuous glucose monitor surface sensor
US10195409B2 (en) 2013-03-15 2019-02-05 Corium International, Inc. Multiple impact microprojection applicators and methods of use
US9962534B2 (en) 2013-03-15 2018-05-08 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US10384046B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
US11565097B2 (en) 2013-03-15 2023-01-31 Corium Pharma Solutions, Inc. Microarray for delivery of therapeutic agent and methods of use
US20160030114A1 (en) * 2013-03-15 2016-02-04 The Research Institute At Nationwide Children's Hospital Medical testing apparatus and method of use
US10653354B2 (en) * 2013-03-15 2020-05-19 Research Institute At Nationwide Children's Hospital Medical testing apparatus and method of use
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
EP3543339A1 (en) 2015-02-13 2019-09-25 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11278678B2 (en) 2016-05-31 2022-03-22 Ndm Technologies Limited In or related to transdermal delivery
WO2018035377A1 (en) 2016-08-17 2018-02-22 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
WO2019030238A1 (en) 2017-08-08 2019-02-14 Isabelle GROZELIER Surface cutting device, in particular for allergy diagnosis
US11571163B2 (en) 2017-08-08 2023-02-07 A2M Surface cutting device, in particular for allergy diagnosis

Also Published As

Publication number Publication date
FR2078137A5 (en) 1971-11-05
DE2105882A1 (en) 1971-08-12
JPS513154B1 (en) 1976-01-31
GB1322294A (en) 1973-07-04

Similar Documents

Publication Publication Date Title
US3675766A (en) Multiple puncture injector device
US3654047A (en) Surgical instrument holder
US3072122A (en) Package for transcutaneous injection
US3777760A (en) Surgical stick
US3164279A (en) Test tube closure
US3221739A (en) Injection device
JP6016885B2 (en) Cap system
US3825150A (en) Waste receptacle having liner bag holders
US20210310734A1 (en) Apparatus for maintaining a controlled environment
US4774063A (en) Container for use with sterilizers
US2990948A (en) Sterile package
US5605160A (en) Allergy testing apparatus with variably spaced test testing sites
US2765832A (en) Mixing bowl
TW200934704A (en) Container and closure thereof
US5147042A (en) Holder for medical specimen slide
US4863023A (en) Shipping and storage container for syringes
EP0028411A1 (en) Stopper for vials
US3073750A (en) Culture dish
US4378876A (en) Display coin holder assemblies
JPH0626875U (en) Sealed cap for injection
US11674751B2 (en) Lyophilisation container
US3396839A (en) Packaging apparatus
US3444989A (en) Casing for devices for intradermal application
JPH0111236Y2 (en)
US2647513A (en) Lyophilzation container